𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Second Malignant Neoplasms: Assessment and Strategies for Risk Reduction

✍ Scribed by Wood, M. E.; Vogel, V.; Ng, A.; Foxhall, L.; Goodwin, P.; Travis, L. B.

Book ID
115535977
Publisher
American Society of Clinical Oncology
Year
2012
Tongue
English
Weight
143 KB
Volume
30
Category
Article
ISSN
0732-183X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Second malignant neoplasms following chi
Second malignant neoplasms following childhood Hodgkin's disease: Treatment and splenectomy as risk factors
✍ Meadows, Anna T. ;Obringer, Angela C. ;Marrero, Osvaldo ;Oberlin, Odile ;Robison πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 680 KB

The risk of second malignant neoplasm (SMN) was evaluated in 979 children with Hodgkin's disease. This cohort was diagnosed between 1955 and 1979 at one of the institutions of the Late Effects Study Group. Solid tumors, non-lymphocytic leukemia, and non-Hodgkin's lymphoma (NHL) developed in 18, 17,

Risk of second malignant neoplasms among
Risk of second malignant neoplasms among lymphoma patients with a family history of cancer
✍ Ola Landgren; Ruth M. Pfeiffer; Laveta Stewart; Gloria Gridley; Lene Mellemkjaer πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 French βš– 73 KB πŸ‘ 2 views

## Abstract Radiotherapy and chemotherapy are known risk factors for second cancers after lymphoma. The role of genetic influences, however, remains largely unknown. We assessed risk of second cancers associated with family history of any cancer in 41,181 patients with Hodgkin lymphoma (HL) (__n__

Long-term risk of second malignant neopl
Long-term risk of second malignant neoplasms after neuroblastoma in childhood: Role of treatment
✍ Carole Rubino; Elisabeth Adjadj; Sylvie GuΓ©rin; Catherine Guibout; Akhtar Shamsa πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 90 KB

## Abstract The aim of our study was to quantify the risk of second malignant neoplasms (SMNs) among long‐term survivors of neuroblastoma and to study the influence of treatment on this risk. We studied data from 544 5‐year survival patients diagnosed with neuroblastoma before age 16 years at 8 Fre